192 related articles for article (PubMed ID: 36451345)
1. B-cell lymphoma-2 family proteins-activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus-2: Killing two birds with one stone?
Soni S; Mebratu YA
Rev Med Virol; 2023 Mar; 33(2):e2411. PubMed ID: 36451345
[TBL] [Abstract][Full Text] [Related]
2. Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.
Cheemarla NR; Watkins TA; Mihaylova VT; Foxman EF
J Infect Dis; 2024 May; 229(5):1430-1434. PubMed ID: 37722683
[TBL] [Abstract][Full Text] [Related]
3. Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1.
Khalil AM; Nogales A; Martínez-Sobrido L; Mostafa A
Front Cell Infect Microbiol; 2024; 14():1357866. PubMed ID: 38375361
[TBL] [Abstract][Full Text] [Related]
4. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
Chen N; Zhang B; Deng L; Liang B; Ping J
Emerg Microbes Infect; 2022 Dec; 11(1):1371-1389. PubMed ID: 35476817
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
6. Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors.
Szczesniak I; Baliga-Gil A; Jarmolowicz A; Soszynska-Jozwiak M; Kierzek E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674746
[TBL] [Abstract][Full Text] [Related]
7. The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic.
Majchrzak M; Poręba M
Pharmacol Rep; 2022 Dec; 74(6):1149-1165. PubMed ID: 35997950
[TBL] [Abstract][Full Text] [Related]
8. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity.
Elaiw AM; Alsulami RS; Hobiny AD
Math Biosci Eng; 2023 Jan; 20(2):3873-3917. PubMed ID: 36899609
[TBL] [Abstract][Full Text] [Related]
9. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
10. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
Oishi K; Horiuchi S; Minkoff JM; tenOever BR
J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
[TBL] [Abstract][Full Text] [Related]
11. Comparison of genome replication fidelity between SARS-CoV-2 and influenza A virus in cell culture.
Kawasaki Y; Abe H; Yasuda J
Sci Rep; 2023 Aug; 13(1):13105. PubMed ID: 37567927
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
[TBL] [Abstract][Full Text] [Related]
13. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
14. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo.
Narayan R; Sharma M; Yadav R; Biji A; Khatun O; Kaur S; Kanojia A; Joy CM; Rajmani R; Sharma PR; Jeyasankar S; Rani P; Shandil RK; Narayanan S; Rao DC; Satchidanandam V; Das S; Agarwal R; Tripathi S
Cell Rep Med; 2023 Aug; 4(8):101127. PubMed ID: 37463584
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.
Higgins CA; Nilsson-Payant BE; Bonaventure B; Kurland AP; Ye C; Yaron TM; Johnson JL; Adhikary P; Golynker I; Panis M; Danziger O; Rosenberg BR; Cantley LC; Martínez-Sobrido L; tenOever B; Johnson JR
mBio; 2023 Aug; 14(4):e0100723. PubMed ID: 37345956
[TBL] [Abstract][Full Text] [Related]
16. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
[TBL] [Abstract][Full Text] [Related]
17. Eight influenza virus cellular manipulations which can boost concurrent SARS-CoV-2 infections to severe outcomes.
Roe K
Hum Cell; 2023 Sep; 36(5):1581-1592. PubMed ID: 37306884
[TBL] [Abstract][Full Text] [Related]
18. Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract.
Dee K; Schultz V; Haney J; Bissett LA; Magill C; Murcia PR
J Infect Dis; 2023 Jun; 227(12):1396-1406. PubMed ID: 36550077
[TBL] [Abstract][Full Text] [Related]
19. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
[TBL] [Abstract][Full Text] [Related]
20. The double-membrane vesicle (DMV): a virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses.
Roingeard P; Eymieux S; Burlaud-Gaillard J; Hourioux C; Patient R; Blanchard E
Cell Mol Life Sci; 2022 Jul; 79(8):425. PubMed ID: 35841484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
